Thermo Fisher Scientific (NYSE:TMO) (NYSE:TMO) is a leading provider of scientific instrumentation, reagents and consumables, and software and services to the global life sciences, biotechnology, pharmaceutical, clinical, academic, government, and industrial markets. The company’s portfolio encompasses analytical instruments such as mass spectrometers and chromatography systems, specialty diagnostics including immunoassays and molecular diagnostics, laboratory products ranging from pipettes to freezers, and comprehensive biopharma services covering development, manufacturing and clinical trial support.
Founded in 2006 through the merger of Thermo Electron Corporation and Fisher Scientific International, Thermo Fisher Scientific has grown organically and through strategic acquisitions to broaden its technology offerings and expand its global footprint. The company has integrated technologies such as genetic sequencing, cell and gene therapy support, and digital laboratory management to address evolving customer needs. Its focus on innovation is underscored by an extensive R&D network and collaborations with academic institutions and industry partners.
Thermo Fisher Scientific operates in more than 50 countries, with major research and manufacturing facilities across North America, Europe, Asia Pacific and Latin America. Its customer base spans large pharmaceutical companies, biotechnology firms, hospitals, universities, and government agencies, as well as industrial users in food safety, environmental testing and applied markets. The company leverages regional technical support teams, field service engineers and digital platforms to deliver customized solutions and ensure compliance with local regulations.
Under the leadership of President and Chief Executive Officer Marc N. Casper, Thermo Fisher Scientific emphasizes a culture of continuous improvement, sustainability and operational excellence. The executive team prioritizes investments in automation, digitalization, and green technologies to drive productivity and reduce environmental impact. Through its commitment to advancing science and supporting customers worldwide, the company aims to enable breakthroughs in research, diagnostics and biopharmaceutical production.
